Prediction of Major Adverse Cardiovascular Events in Patients with Hypertrophic Cardiomyopathy by Deep Learning and
Jiangtao Wang1, Biaohu Liu2, Caiyun Xia2
1Department of Ultrasound Medicine, The First Affiliated Hospital of Wannan Medical College, Wuhu, China, wjtwjt1024@163.com.
Cardiology
|July 13, 2025
Summary
This study introduces the DTL-RAD model, combining deep transfer learning and radiomics to predict major adverse cardiovascular events (MACE) in hypertrophic cardiomyopathy (HCM) patients, enabling early intervention.
Area of Science:
- Cardiology
- Medical Imaging
- Artificial Intelligence
Background:
- Hypertrophic cardiomyopathy (HCM) patients face risks of major adverse cardiovascular events (MACE).
- Accurate risk stratification is crucial for timely intervention in high-risk HCM patients.
- Existing methods lack comprehensive predictive capabilities for MACE in HCM.
Purpose of the Study:
- To develop and validate a predictive model for MACE in HCM patients.
- To combine deep transfer learning (DTL) and radiomics for enhanced risk prediction.
- To assess the clinical utility of the novel DTL-RAD model.
Main Methods:
- Retrospective analysis of 210 HCM patients with a mean follow-up of 29.44 months.
- Extraction of radiomic features from echocardiographic images and DTL features using Resnet50.
- Development of the DTL-RAD model using selected features and machine learning algorithms.
Main Results:
- The DTL-RAD model achieved excellent diagnostic performance (AUC 0.936 training, 0.918 validation).
- The model significantly outperformed standalone radiomics or DTL models.
- Decision curve analysis confirmed superior clinical applicability and effectiveness of the DTL-RAD model.
Conclusions:
- The DTL-RAD model accurately identifies HCM patients at high risk for MACE.
- Early detection of high-risk individuals facilitates precise clinical interventions.
- This approach can effectively reduce MACE incidence in HCM patients.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
54
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
54
Cardiomyopathy V: Interprofessional Care
37
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
37
Imaging Studies for Cardiovascular System III: X-Ray
299
The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
299

